Literature DB >> 19669623

Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007.

Adrian Schmassmann1, Marie-Gabrielle Oldendorf, Jan-Olaf Gebbers.   

Abstract

Several Western countries have reported a decrease in the incidence of noncardia gastric adenocarcinoma and a strong increase in the incidence of oesophageal and cardia adenocarcinoma. We examined incidence rates of gastric and oesophageal cancer by subsite and histology in Central Switzerland over the last 26 years. Data on biopsy-diagnosed gastric and oesophageal carcinoma incidence during 1982-2007 were obtained from the Cancer Registry of the Institute of Pathology, Lucerne, the Medical Centre for Central Switzerland. Age-adjusted (standardized to the European standard population), and sex-specific incidence rates were calculated. In total, 2,322 cancers were diagnosed: 1,240 noncardia gastric adenocarcinomas, 459 cardia gastric adenocarcinomas, 248 oesophageal adenocarcinomas, and 375 squamous cell carcinomas. From 1982 to 2007, the incidence rates of noncardia adenocarcinoma decreased substantially from 17.9 (per 100,000) to 6.0 in men and 10.3 to 5.5 in women. In men, the incidence of gastric cardia adenocarcinoma decreased from 7.5 to 4.3, the incidence of oesophageal adenocarcinoma increased from 3.3 to 4.8, and the incidence of oesophageal squamous cell carcinoma decreased from 6.6 to 4.1; the incidence rates of these cancers were low in women (1.1-2.4). In conclusion, the incidence of gastric noncardia carcinoma has decreased substantially over the past 26 years. In contrast to other Western countries, the incidence of gastric cardia adenocarcinoma did not increase in Central Switzerland. Whereas the rate of oesophageal adenocarcinoma increased, the rate of squamous cell carcinoma decreased. These results suggest substantial changes in environmental and life-style risk factors over the past 26 years.

Entities:  

Mesh:

Year:  2009        PMID: 19669623     DOI: 10.1007/s10654-009-9379-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  35 in total

1.  Linking Helicobacter pylori to gastric cancer.

Authors:  M J Blaser
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

2.  Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992.

Authors:  R W Armstrong; B Borman
Journal:  Int J Epidemiol       Date:  1996-10       Impact factor: 7.196

3.  Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries.

Authors:  A A Botterweck; L J Schouten; A Volovics; E Dorant; P A van Den Brandt
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

4.  Attributable risks for oesophageal cancer in northern Italy.

Authors:  E Negri; C La Vecchia; S Franceschi; A Decarli; P Bruzzi
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

5.  Association between body mass and adenocarcinoma of the esophagus and gastric cardia.

Authors:  J Lagergren; R Bergström; O Nyrén
Journal:  Ann Intern Med       Date:  1999-06-01       Impact factor: 25.391

6.  Increasing prevalence of adenocarcinoma of the oesophagus and gastro-oesophageal junction: a study of the Swedish population between 1970 and 1997.

Authors:  C Walther; T Zilling; R Perfekt; T Möller
Journal:  Eur J Surg       Date:  2001-10

7.  Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA.

Authors:  H B El-Serag; A C Mason; N Petersen; C R Key
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

8.  Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma.

Authors:  L E Hansson; L Engstrand; O Nyrén; D J Evans; A Lindgren; R Bergström; B Andersson; L Athlin; O Bendtsen; P Tracz
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

9.  Incidence of cancer of oesophagus, cardia and stomach in Denmark.

Authors:  H Møller
Journal:  Eur J Cancer Prev       Date:  1992-02       Impact factor: 2.497

10.  Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.

Authors:  J Powell; C C McConkey
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

View more
  11 in total

1.  Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany.

Authors:  Katrin Hertrampf; Jörg Wiltfang; Alexander Katalinic; Olaf Timm; Hans-Jürgen Wenz
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-14       Impact factor: 4.553

2.  The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design.

Authors:  Xin Gao; Albert Hofman; Yu Hu; Huandong Lin; Chouwen Zhu; Johannes Jeekel; Xuejuan Jin; Jiyao Wang; Jian Gao; Yiqing Yin; Naiqing Zhao
Journal:  Eur J Epidemiol       Date:  2010-12-01       Impact factor: 8.082

3.  Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5.

Authors:  L A Anderson; A Tavilla; H Brenner; S Luttmann; C Navarro; A T Gavin; B Holleczek; B T Johnston; M B Cook; F Bannon; M Sant
Journal:  Eur J Cancer       Date:  2015-09-26       Impact factor: 9.162

Review 4.  Basis for molecular diagnostics and immunotherapy for esophageal cancer.

Authors:  Joe Abdo; Devendra K Agrawal; Sumeet K Mittal
Journal:  Expert Rev Anticancer Ther       Date:  2016-11-23       Impact factor: 4.512

5.  The descriptive epidemiology of gastric cancer in Central America and comparison with United States Hispanic populations.

Authors:  Juan E Corral; Juan J Delgado Hurtado; Ricardo L Domínguez; Marisabel Valdez de Cuéllar; Carlos Balmore Cruz; Douglas R Morgan
Journal:  J Gastrointest Cancer       Date:  2015-03

6.  Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between the United States, Spain, and the Netherlands.

Authors:  S Kroep; I Lansdorp-Vogelaar; J H Rubenstein; V E P P Lemmens; E B van Heijningen; N Aragonés; M van Ballegooijen; J M Inadomi
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

7.  New studies, technology, and the progress of epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-12       Impact factor: 8.082

8.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

Review 9.  Immunotherapy in gastroesophageal cancers: Current state and future directions.

Authors:  Hira Shaikh; Amir Kamran; Dulabh K Monga
Journal:  J Oncol Pharm Pract       Date:  2020-10-13       Impact factor: 1.809

10.  Association between Dietary Vitamin E Intake and Esophageal Cancer Risk: An Updated Meta-Analysis.

Authors:  Lingling Cui; Li Li; Yalan Tian; Fan Xu; Tianyi Qiao
Journal:  Nutrients       Date:  2018-06-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.